登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Endoglin】

Endoglin信息

英文名称:Endoglin
中文名称:内皮因子
靶点别称:CD105 Antigen,CD105,END,ENG,Osler-Rendu-Weber Syndrome 1,HHT1,ORW1,Endoglin
上市药物数量:0
临床药物数量:3
最高研发阶段:临床三期

Endoglin产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
ENN-H52H9
Human
Human Endoglin / CD105 Protein, His Tag
ACRO质量管理体系
 
评论(0)
 

Endoglin 分子别名

Endoglin,CD105,ENG,END

Endoglin 分子背景

Endoglin (ENG), endothelial glycoprotein, also known as CD105, is a coreceptor of the transforming growth factor-β (TGFβ) family signaling complex, which is highly expressed on endothelial cells and plays a key role in angiogenesis. It regulates the responses associated with binding to transforming growth factor β1 egg (Activin-A), bone morphogenetic protein 2 (BMP-2), and bone morphogenetic protein 7 (BMP-7). Endoglin may be involved in autosomal dominant disease, such as hereditary hemorrhagic telangiectasia 1 (HHT1). Circulating soluble ENG is also elevated in pulmonary arterial hypertension(PAH) and is proposed to be a biomarker for the prognosis of group I PAH patients.

Endoglin 前沿进展

Endoglin临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定